The PRognostic Effect of Environmental Factors in Crohn's and Colitis
NCT03282903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2629
Last updated 2024-05-20
Summary
The PREdiCCt Study:
This is a major study that is now being launched. This is the first study of its kind and is specifically directed toward understanding how environmental factors and the gut microorganisms influence IBD flare and recovery. For the PREdiCCt study, the investigators hope to recruit 3100 people in remission from Crohn's disease or ulcerative colitis (illness under control) from 28 inflammatory bowel disease clinics across the UK.
The investigators hope to conduct the study in the following stages;-
1. Patients with Crohn's disease, ulcerative colitis or inflammatory bowel disease unclassified (IBDU) in clinical remission (under control) will be approached in gastroenterology clinics across the country and invited to take part in the PREdiCCt study. Alternatively they will express their interest in the study after seeing PREdiCCt promotional leaflets/posters/videos/social media.
2. Participants will attend a clinic visit for routine tests and also to complete several questionnaires with a research nurse.
3. At home over the next week participants will complete detailed questionnaires assessing their environment and diet. Participants will also collect a stool and saliva sample and send this to our laboratories (the investigators have developed easy ways of doing this reliably by post). The stool sample is to analyse the microorganisms in the participant's gut and the saliva is used to analyse their DNA. In addition to this the participants are asked to complete a 4-day weighed food diary. The food diary is sent to the University of Aberdeen for analysis.
4. Investigators will then follow patients' progress over 24 months. They will be asked to complete a short questionnaire every month with a longer questionnaire after 12 months and culminating in a final questionnaire 24 months after their initial clinic visit.
5. If a participant experiences a flare, investigators will collect an additional stool sample; but most importantly investigators will look to see how the environmental and microorganism factors recorded at the beginning differ for those that flare up versus those that don't.
What investigators hope to achieve;-
1. Finding out the environmental and dietary factors for patients to avoid because they trigger flare.
2. Finding out behaviours for patients to adopt because they bring about remission.
3. Finding out what the microorganisms that predict flare look like.
4. Gaining information which helps future studies aimed at finding better diets for IBD sufferers.
5. Developing ways of gathering information online from IBD patients about their well-being that doctors can routinely use.
The investigators have assembled expert doctors, epidemiologists, microbiologists, nutrition scientists, and bioinformaticians. These experts will use the systems the investigators have put in place to make sure PREdiCCt succeeds. It will yield a lot of new information to help sufferers right away; but the information will also help to kick start many important future studies that will bring us ever closer to a cure for Crohn's disease and ulcerative colitis.
Conditions
- Inflammatory Bowel Diseases
- Crohn Disease
- Ulcerative Colitis
Sponsors & Collaborators
-
University of Aberdeen
collaborator OTHER -
Wellcome Sanger Institute
collaborator OTHER -
NHS Lothian
collaborator OTHER_GOV -
Chief Scientist Office of the Scottish Government
collaborator OTHER_GOV -
Crohn's and Colitis in Childhood
collaborator UNKNOWN -
Cure Crohn's and Colitis
collaborator UNKNOWN -
Edinburgh and Lothain Health Fund (Lothian Health Board)
collaborator UNKNOWN -
University of Edinburgh
lead OTHER
Principal Investigators
-
Charlie Lees · University of Edinburgh
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-01
- Primary Completion
- 2020-03-20
- Completion
- 2022-03-20
Countries
- United Kingdom
Study Locations
More Related Trials
-
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
NCT00572780 ·Status: COMPLETED
-
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
NCT03566407 ·Status: TERMINATED ·Phase: NA
-
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
NCT03668249 ·Status: COMPLETED
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
NCT00790543 ·Status: COMPLETED
-
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD
NCT03994224 ·Status: TERMINATED
-
Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study
NCT06896305 ·Status: RECRUITING ·Phase: NA
-
Study of an Environmental Risk Factor in Crohn's Disease
NCT04960826 ·Status: RECRUITING
-
The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.
NCT06006039 ·Status: RECRUITING
-
Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
NCT03090139 ·Status: COMPLETED
-
Remote Monitoring of IBD
NCT05886322 ·Status: UNKNOWN
-
Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease
NCT03376230 ·Status: TERMINATED
-
Fecal Transplant for Crohn's Disease
NCT03078803 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
NCT00306215 ·Status: COMPLETED ·Phase: PHASE2
-
Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Crohn's Disease
NCT06933264 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease
NCT03885713 ·Status: COMPLETED ·Phase: PHASE4
-
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
NCT05332639 ·Status: RECRUITING ·Phase: NA
-
Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease
NCT04283864 ·Status: ACTIVE_NOT_RECRUITING
-
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
NCT06453720 ·Status: RECRUITING
-
Impact of the Fecal Flora Transplantation on Crohn's Disease
NCT02097797 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin
NCT06972901 ·Status: RECRUITING ·Phase: NA
-
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
NCT02054533 ·Status: COMPLETED
-
Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
NCT00102921 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Inflammatory Bowel Diseases
NCT02612103 ·Status: COMPLETED
-
Comparison of Environmental Factors Between the Areas of Over- and Under-incidence of Crohn's Disease in the Haut de France Region, by the Study of Dental Exposomes
NCT03706196 ·Status: COMPLETED